Newborn News and Research

RSS

New method studies how newborn baby's brain responds to being touched on face

A newborn baby's brain responds to being touched on the face, according to new research co-led by UCL.

19 Nov 2018

New first-line treatment for peripheral T-cell lymphoma approved by FDA

The U.S. Food and Drug Administration today expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma.

16 Nov 2018

Researchers awarded $10 million grant to address root causes of asthma in Puerto Rico

Researchers at the University of California, San Francisco, National Jewish Health and Centro de Neumología Pediátrica in Puerto Rico have been awarded nearly $10 million as part of a 5-year grant from the U.S. National Heart Lung and Blood Institute, part of the National Institutes of Health, to address the root causes of asthma by studying 4,000 children in Puerto Rico, where asthma prevalence and deaths are among the highest in the world.

16 Nov 2018

New 15-minute scan could help diagnose brain damage in babies up to two years old

A 15-minute scan could help diagnose brain damage in babies up to two years earlier than current methods. In a study of over 200 babies at seven hospitals across the UK and the USA, researchers found the brain scan, called magnetic resonance spectroscopy, predicted damage with 98 percent accuracy.

15 Nov 2018

The Human Mini Heart-in-a-Jar That Could One Day Replace Animal Testing

An interview with Dr. Kevin Costa, discussing the miniaturized heart-in-a-jar model developed by Novoheart, and its applications in personalized medicine.

12 Nov 2018

Study explains how dermal fibroblasts age

With age, our tissues lose their function and capacity to regenerate after being damaged. A study published today in Cell by scientists at the Institute for Research in Biomedicine and the Centro Nacional de Análisis Genómico of the Center for Genomic Regulation explains how dermal fibroblasts age.

8 Nov 2018

Breastmilk and saliva mixtures regulate oral microbiome of newborn babies

A study led by Dr Emma Sweeney and Adjunct Associate Professor Christine Knox, from QUT's Institute of Health and Biomedical Innovation, with colleagues at the University of Queensland, showed that the growth of some microbes was inhibited for up to 24 hours following breastmilk and saliva mixing.

8 Nov 2018

Premature births on the rise in the US says March of Dimes report

The annual report on preterm births from March of Dimes was released and the results show that there has been a consistent rise in rates of preterm births for three consecutive years.

2 Nov 2018

Genetic testing and breakthrough therapies may transform diagnosis, care of neuromuscular disease

A new report funded by the Muscular Dystrophy Association and released by the IQVIA Institute for Human Data Science indicates that genetic testing and breakthrough therapies will transform the diagnosis and care of neuromuscular disease within the next decade.

31 Oct 2018

King's researchers analyze potential risks of C-section

A series of papers published in the Lancet shows that globally the number of babies born through cesarean section (C-section) almost doubled between 2000 and 2015: from 12% to 21% of all births or nearly 30 million worldwide.

26 Oct 2018

Study finds why pregnant women in mainland China, Hong Kong and Taiwan prefer cesarean delivery

Pregnant women in mainland China, Hong Kong, and Taiwan are more likely to express preference for cesarean section as their mode of delivery later in pregnancy and postpartum, as compared to early in pregnancy, according to a study published this week in PLOS Medicine.

19 Oct 2018

Elective induction of labor at 39 weeks may be beneficial option for women and their babies

As the prevalence of maternal and fetal complications increases with advancing pregnancy beyond 39 weeks, induction of labor at 39 weeks has been proposed as a means to ensure optimal maternal and newborn health.

17 Oct 2018

Males who spend more time taking care of kids have greater reproductive success

Males have greater reproductive success if they spend more time taking care of kids -- and not necessarily only their own, according to new research published by anthropologists at Northwestern University.

15 Oct 2018

Pediatric device consortium co-led by Children's National and UMD receives $5 million from FDA

To foster development, production and marketing of the next generation of medical devices designed to meet growing children's unique needs, the Food and Drug Administration awarded $5 million to the National Capital Consortium for Pediatric Device Innovation, led by Children's National Health System and University of Maryland, College Park.

11 Oct 2018

‘Grossly unfair’? Widower takes ban on military injury claims to Supreme Court

More than four years after Navy Lt. Rebekah Daniel bled to death within hours of childbirth at a Washington state military hospital, her husband still doesn't know exactly how — or why — it happened.

11 Oct 2018

New genome editing tool used to heal genetic disease

Parents of newborns may be familiar with the metabolic disorder phenylketonuria: in Switzerland, all newborn babies are screened for this genetic disease.

8 Oct 2018

Leadiant Biosciences announces FDA approval of Revcovi for treating pediatric, adult ADA-SCID patients

Leadiant Biosciences, Inc. today announced that the Food and Drug Administration has granted approval to Revcovi (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy for the treatment of adenosine deaminase severe combined immune deficiency in pediatric and adult patients.

7 Oct 2018

ACMG’s NICHD contract extended for Newborn Screening Translational Research Network

The American College of Medical Genetics and Genomics (ACMG) has been awarded a five-year extension of its NICHD contract for The Newborn Screening Translational Research Network (NBSTRN).

5 Oct 2018

FDA approves HEMLIBRA for treatment of hemophilia A

Chugai Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved HEMLIBRA (US generic name: emicizumab-kxwh), a treatment for hemophilia A created by Chugai, for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A without factor VIII inhibitors, administered once weekly, every two weeks, or every four weeks.